8GNRL announces successful completion of third well K#13 in Kanawara field; production expected to rise by up to 100 BOPD [GNRL]
8CPCL achieves record throughput and strong profit rebound in Q2 FY2025-26 [CPCL]
8Financial results for the quarter and six months ended September 30, 2025 [CPCL]
8Operational issues at HPCL Mumbai refinery due to high salt and chloride content in crude sourced from HOECL’s B-80 field [HPCL]
8Appointment of statutory auditors for the year 2025-26 [IOCL]
8Investor presentation – Q2 FY2025-26 [IOCL]
8Financial results for the quarter and half year ended September 30, 2025 [IOCL]
8Monthly report on crude oil and petroleum products – September 2025 [PPAC]
8Public notice inviting comments on draft guidelines for CBG injection into NGPL and CGD infrastructure [PNGRB]
8Board meeting and investor call on November 4, 2025 to approve Q2 & H1 FY2025-26 results [Adani Port]

8Intimation regarding independent ESG score of 56 assigned by CFC Finlease Private Limited [RIL]
8Cessation of Ms. Shilpa Sachdeva as senior management personnel of PI Industries Limited effective October 26, 2025 [PIIL]
8Favorable court ruling for Tata Chemicals Magadi Ltd in land rates dispute with Kajiado County, Kenya [TCL]
8Rama Phosphates seeks shareholder approval via postal ballot for Employee Stock Option Plan 2025 [RPL]
8Financial results for half year ended September 30, 2025 [TGEIL]

8Get exclusive access to today's complete price matrix from the Mumbai chemical market
8Stay ahead with the latest rates and trends across key commodities and chemicals

8Styrene Monomer was little changed over the past month
8Last week’s print is down by Re 0.5/kg from last week

8Toluene was little changed over the past year
8This week’s print improved by Re 1.0/kg from last week

8Vinyl Acetate Monomer was little changed over the past six months
8This week’s cadence stayed quiet, with minimal day-to-day shifts

8Propylene Glycol was little changed over the past month
8YoY context remains even, with no outsized swings

8Phenol rose Rs 0.5/kg this week
8Three-month context remains firm without sharp day-to-day swings

8N-Propyl Acetate is up Rs 0.75/kg over the past month
8Weekly movements were small and orderly in the domestic market

8n-Butanol slipped Rs 2/kg over the past fortnight but has held its ground this week
8The domestic series is stabilising rather than trending

8Octanol is largely unchanged when viewed over three months, though the series has eased during that period
8The current read shows a tight domestic range rather than a directional push

8Orthoxylene moved up by Rs 4/kg this week
8The product now sits near the upper end of its recent domestic range

8Against a six-month reference, Monoethylene Glycol is almost unchanged
8Over the last fortnight, it added Rs 1.5/kg, but the broader pace remains calm

8Mixed Xylene Isomer added Rs 3/kg over the last fortnight
8The month view shows a Rs 4/kg rise, keeping the tone constructive without sharp swings

8Mixed Xylene is up Rs 9/kg over the past month
8The fortnight change adds Rs 6/kg, putting focus on near-high levels

8Mixed Xylene is up Rs 9/kg over the past month
8The fortnight change adds Rs 6/kg, putting focus on near-high levels

8Over a three-month view, Methylpropanediol is lower by Rs 5/kg
8The six-month reference shows a deeper decline of Rs 21/kg, though week-to-week conditions are calm

8The week was flat for Methyl Methacrylate, while the month view shows a Rs 2/kg slip
8Day-to-day movement stayed limited

8Explore the latest bulk chemical prices from the Mumbai market, updated for today
8Stay informed with comprehensive insights into key commodities and trends

8Get exclusive access to today's complete price matrix from the Mumbai chemical market
8Stay ahead with the latest rates and trends across key commodities and chemicals

8Vedanta’s long-term rating stays at ‘CRISIL AA / Watch Developing’
8Short-term rating is reaffirmed at CRISIL A1+
8The agency cited ongoing assessment under evolving conditions

8IOL Pharmaxis UK Ltd has been formed as a 100% subsidiary
8The unit will operate in pharmaceuticals and chemicals, with initial capital of GBP 10,000

8The company will present its unaudited and audited results for the September quarter
8The meeting date has been confirmed as November 1

8The meeting will review standalone and consolidated Q2 FY26 results
8Trading restrictions apply until 48 hours post-board approval

8The company has confirmed the accuracy of reports on its new ADC bioconjugation suite
8The expansion enables end-to-end ADC production
8Syngene said the initiative is part of normal business operations